Guardant Health Inc [GH] stock is trading at $63.43, up 2.50%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GH shares have gain 8.30% over the last week, with a monthly amount glided 43.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on April 10, 2025, when Mizuho initiated its Outperform rating and assigned the stock a price target of $55. Previously, Barclays started tracking the stock with Overweight rating on January 23, 2025, and set its price target to $60. On June 28, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $36 on the stock. In a note dated December 13, 2023, Wolfe Research initiated a Peer Perform rating.
Guardant Health Inc [GH] stock has fluctuated between $20.14 and $62.81 over the past year. Currently, Wall Street analysts expect the stock to reach $61 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $63.43 at the most recent close of the market. An investor can expect a potential drop of -3.83% based on the average GH price forecast.
Analyzing the GH fundamentals
Guardant Health Inc [NASDAQ:GH] reported sales of 828.85M for the trailing twelve months, which represents a growth of 30.95%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.56%, Pretax Profit Margin comes in at -0.5%, and Net Profit Margin reading is -0.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is 2.19 and Total Capital is -0.42. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-4.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 62.46 points at the first support level, and at 61.49 for the second support level. However, for the 1st resistance point, the stock is sitting at 63.94, and for the 2nd resistance point, it is at 64.45.
Ratios To Look Out For
For context, Guardant Health Inc’s Current Ratio is 3.71. Further, the Quick Ratio stands at 3.35, while the Cash Ratio is 2.64. Considering the valuation of this stock, the price to sales ratio is 9.54.
Transactions by insiders
Recent insider trading involved Kalia Kumud, Chief Information Officer, that happened on Aug 21 ’25 when 2000.0 shares were sold. Officer, Kalia Kumud completed a deal on Aug 21 ’25 to buy 2000.0 shares. Meanwhile, Director Tariq Musa sold 116.0 shares on Aug 19 ’25.
